SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following the European Commission's conditional authorization of ANKTIVA, significantly expanding its market to 33 countries for hard-to-treat bladder cancer. The community is buzzing with intensifying expectations of a massive short squeeze and further global approvals, anticipating a substantial re-evaluation of the stock as a globally validated oncology company.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc (FJET) is rallying as its IPO quiet period recently concluded, intensifying community debate around a potential short squeeze driven by its tiny float and high short interest, with investors also eyeing an anticipated FAA Space Launch license and broader sector tailwinds from the rumored Space X IPO.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending amidst strong community speculation over activist investor Nelson Peltz's comments on its undervaluation, driving discussions of a potential buyout or short squeeze following recent market movements.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its earnings report delivered a revenue beat but lowered profit guidance, fueling a sell-off amid broader software sector concerns. The community is sharply divided between those predicting further declines due to acquisition costs and others viewing the dip as a significant buying opportunity, citing strong cybersecurity demand amplified by AI threats.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a significant increase in institutional ownership by Cormorant Asset Management, seen by the community as a strong validation of its 'best-in-class' nanobody platform. Investors are keenly anticipating the upcoming investor day and clinical data updates, fueling speculation about a potential re-rating and short squeeze due to its perceived undervaluation and high short interest.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly anticipates its BLA resubmission for Deramiocel by month-end, following robust Phase 3 HOPE-3 data for Duchenne Muscular Dystrophy. Investors are closely watching for this regulatory milestone, alongside increasing institutional ownership and ongoing discussions around broader FDA consistency that could impact biotechs like CAPR.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending following news of its multi-year U.S. brewing and commercial partnership with the Carlsberg Group, particularly for CBD beverages. Community discussion centers on whether this strategic collaboration signifies a major beverage market expansion and future cannabis entry for big alcohol, or if it's a non-committal deal diverting from core cannabis sector challenges.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as conversations buzz around promising "physical silicon results" for its Mears Silicon Technology (MST) in Gate-All-Around (GAA) nanosheets, hinting at significant power savings for AI chips, and its GaN-on-Si concept advancing to a proposal stage. This technical progress, coupled with unprecedented trading volume and management's renewed confidence with performance-linked bonuses, fuels a community debate between long-awaited commercial breakthroughs and concerns over the pre-revenue company's history of speculative hype.

PENN Entertainment, Inc. engages in the provision of integrated entertainment, sports content, and casino gaming services. It operates through the following business segments: Northeast, South, West, Midwest, Interactive, and Other. The Northeast segment includes Ameristar East Chicago, Hollywood Casino, Hollywood Gaming, Marquee, and Plainridge Park Casino operations. The South segment manages 1st Jackpot Casino, Ameristar Vicksburg, Boomtown, Hollywood Casino Gulf Coast, Hollywood Casino Tunica, L’Auberge, and Margaritaville Resort Casino. The West segment is involved in Ameristar Black Hawk, Cactus Petes and Horseshu, M Resort Spa Casino, and Zia Park Casino operations. The Midwest segment focuses on Ameristar Council Bluffs, Argosy Casino, Hollywood Casino, Prairie State Gaming, and River City Casino operations. The Interactive segment refers to an online gaming portfolio which includes ESPN BET, Hollywood Casino, theScore Bet, and PENN Game Studios. The Other segment consists of stand-alone racing operations, namely Sanford-Orlando Kennel Club, Sam Houston, and Valley Race Park. The company was founded by Peter M. Carlino in 1982 and is headquartered in Wyomissing, PA.

PENN Entertainment Inc

PENN Entertainment Inc.

PENN Entertainment is trending due to widespread shareholder discontent following the costly termination of its ESPN Bet partnership and rebranding to theScore Bet, fueling calls for CEO Jay Snowden's removal. The community is actively discussing the stock's multi-year lows and advocating for a spin-off of the struggling digital betting segment to prioritize its stable regional casino operations.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop (WING) is trending after reporting a mixed Q4, with an EPS beat but a revenue miss and a conservative domestic same-store sales outlook. Despite the mixed results, the stock has shown significant relative strength and upward price action, fueling community discussions about a potential short squeeze and prompting analyst upgrades that emphasize its international growth and operational efficiency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>For Q4 2025, GE Vernova reported a better-than-expected revenue of $10.96 billion</li><li>Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit.</li><li>China Renaissance initiated stock coverage with a ‘Buy’ rating and a price target of $966.</li></ul>GE Vernova (GEV) on Wednesday raised its full-year 2026 and 2028 revenue guidance, following regulatory approval for the acquisition of Prolec GE, which is expected to close on Feb. 2, 2026.For FY 2026, the company now forecasts revenue of $44 billion to $45 billion, up from $41 billion to $42 billion, with an adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin of 11% to 13%.&nbsp;Segment-wise, Power is expected to deliver 16% to 18% organic revenue growth with margins of 16% to 18%. Wind revenue is projected to decline at a low double-digit rate, with an EBITDA loss of around $400 million, while Electrification revenue is seen at $13.5 billion to $14 billion, including roughly $3 billion from Prolec GE.Looking ahead to FY2028, the company now targets $56 billion in revenue, up from the $52 billion it had forecast earlier.<h2 class="st-heading-2">Q4 Results</h2>For Q4 2025, GE Vernova reported revenue of $10.96 billion, up 4%, and above Wall Street estimates of $10.22 billion, according to Fiscal.ai data. Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit. &nbsp;The company also declared a quarterly dividend of $0.50 per share.<a href="https://stocktwits.com/symbol/GEV">GEV stock</a> was down nearly 3% in pre-market trading but climbed marginally higher after the opening bell.“Given our strong free cash flow generation, we ended the quarter with a healthy cash balance of nearly $9 billion, which continues to give us confidence to invest in our core businesses and return cash to shareholders through our share repurchase actions and quarterly dividend payment, while maintaining a strong investment grade balance sheet,” said&nbsp;GE Vernova CFO&nbsp;Ken Parks.&nbsp;Separately, China Renaissance initiated coverage of GE Vernova with a ‘Buy’ rating and a price target of $966.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘neutral,’ amid ‘extremely high’ message volumes.One user spoke about the stock’s steady upside move.<stembedurl>https://stocktwits.com/terrin07/message/643149766</stembedurl>One user speculated on why the stock's movement didn’t align with the overall earnings.<stembedurl>https://stocktwits.com/Mahvalousday/message/643119968</stembedurl>The stock has gained over 97% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the GE Vernova company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Why Is GEV Stock Drawing Investor Attention Today?

GE Vernova now expects 2026 revenue of $44–$45 billion, up from $41–$42 billion, and lifted its 2028 revenue target to $56 billion from $52 billion.

Equity

Rising demand for 2x Leveraged Daily ETFs tied to AI infrastructure stocks such as CoreWeave and NuScale PowerNEW YORK, July 24, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=1914267937&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs%2C">Tradr ETFs,</a> a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its five newest leveraged ETFs: the Tradr 2X Long CRWV Daily ETF (Cboe: CWVX), the Tradr 2X Long SMR Daily ETF (Cboe: SMU), the Tradr 2X Long ASTS Daily ETF (Cboe: ASTX), the Tradr 2X Long GEV Daily ETF (Cboe: GEVX), and the Tradr 2X Long CEG Daily ETF (Cboe: CEGX).The five ETFs, all first-to-market products launched on July 11, have rapidly gained traction among traders seeking 200% daily long exposure to highly watched and liquid single stocks. Four of those names, CoreWeave (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">CRWV</a>), NuScale Power (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">SMR</a>), GE Vernova (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">GEV</a>) and Constellation Energy (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">CEG</a>), are tied to the AI buildout theme, while AST SpaceMobile (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html#financial-modal">ASTS</a>) is setting the standard for a global satellite network focused on mobile phone users."In&nbsp;just&nbsp;eight&nbsp;trading days,&nbsp;these&nbsp;five&nbsp;ETFs&nbsp;have&nbsp;accumulated&nbsp;over&nbsp;$60&nbsp;million in&nbsp;assets&nbsp;which&nbsp;we&nbsp;believe really validates the thirst investors have for these types of long exposures," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "With the start of options trading, traders have even more choice to amplify their high-conviction ideas on five very exciting stocks."For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=849917014&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=4234011838&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr%C2%A0ETFs">Tradr&nbsp;ETFs</a>&nbsp;are designed&nbsp;for&nbsp;sophisticated&nbsp;investors and&nbsp;professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT&nbsp;RISK&nbsp;INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier&nbsp;than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4473963-1&amp;h=849917014&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed&nbsp;by&nbsp;ALPS&nbsp;Distributors,&nbsp;Inc,&nbsp;which&nbsp;is&nbsp;not&nbsp;affiliated&nbsp;with&nbsp;AXS&nbsp;Investments&nbsp;or&nbsp;its&nbsp;Tradr&nbsp;ETFs.&nbsp;AXI000718SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit the article.

Options Trading Now Available on Latest Five Tradr ETFs: CWVX, SMU, ASTX, GEVX and CEGX

https://www.prnewswire.com/news-releases/options-trading-now-available-on-latest-five-tradr-etfs-cwvx-smu-astx-gevx-and-cegx-302512313.html

Others

Investment Managers Series Trust II - Tradr 2X Long GEV Daily ETF

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

Current Price	$47.62
Prev Close	$47.42
Open	$47.98
Dividend Yield	N/A
50-Day Moving Average	$34.82
Beta	N/A
Avg. Volume	154,101.65
PE Ratio	N/A

52-Week High	$50.37
52-Week Low	$21.63
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

GEVX
Tradr 2X Long GEV Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Latest GEVX News

GEVXTradr 2X Long GEV Daily ETF